CLL Specific Neutra™ Antibody (V3S-0324-FY49), Human IgG (CAT#: V3S-0324-FY49)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This is a recombinant human antibody that binds to human CLL. The antibody bound 6.8% of apoptotic Jurkat T cells. It can bind apoptotic B and T cells with a concentration of 50 μg/mL by flow cytometry assay. It is utilized in both Inhib and ELISA assays, with concentrations of 25 μg/mL for both the Inhib assay and the ELISA assay.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application Inhib; FC; ELISA
Application Notes FC: 50 μg/mL
Inhib: 25 μg/mL
ELISA: 25 μg/mL

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CLL
Alternative Name Chronic lymphocytic leukemia; CLL
Research Area Apoptosis
For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry